NeuroMetrix, Inc. - stock earnings
NURO Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 1, 2024 BeforeMarket | - / - | - | - / 22.3 million | - |
NURO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -1.6 million USD | 1.3 million USD |
| 2023Q3 | -1.8 million USD | 1.2 million USD |
| 2023Q2 | -1.5 million USD | 1.7 million USD |
| 2023Q1 | -1.4 million USD | 1.7 million USD |
| 2022Q4 | -681649 USD | 1.8 million USD |
| 2022Q3 | -1.5 million USD | 2.0 million USD |
| 2022Q2 | -1.1 million USD | 2.1 million USD |
| 2022Q1 | -955134 USD | 2.3 million USD |
| 2021Q4 | -1.0 million USD | 1.8 million USD |
| 2021Q3 | -687089 USD | 2.1 million USD |
| 2021Q2 | -531584 USD | 2.2 million USD |
| 2021Q1 | -59783 USD | 2.2 million USD |
| 2020Q4 | -325767 USD | 1.8 million USD |
| 2020Q3 | -257113 USD | 2.0 million USD |
| 2020Q2 | -851944 USD | 1.4 million USD |
| 2020Q1 | -657371 USD | 2.2 million USD |
| 2019Q4 | -1.1 million USD | 1.7 million USD |
| 2019Q3 | -1.4 million USD | 2.1 million USD |
| 2019Q2 | -3.4 million USD | 2.4 million USD |
| 2019Q1 | 2.1 million USD | 3.1 million USD |
| 2018Q4 | -2.8 million USD | 3.7 million USD |
| 2018Q3 | 1.1 million USD | 3.7 million USD |
| 2018Q2 | 573928 USD | 3.8 million USD |
| 2018Q1 | 1.2 million USD | 4.9 million USD |
| 2017Q4 | -2.9 million USD | 4.9 million USD |
| 2017Q3 | -3.5 million USD | 3.5 million USD |
| 2017Q2 | -3.2 million USD | 4.3 million USD |
| 2017Q1 | -3.2 million USD | 4.3 million USD |
| 2016Q4 | -2.8 million USD | 3.7 million USD |
| 2016Q3 | -3.9 million USD | 3.4 million USD |
| 2016Q2 | -4.1 million USD | 2.6 million USD |
| 2016Q1 | -4.1 million USD | 2.3 million USD |
| 2015Q4 | -2.7 million USD | 2.7 million USD |
| 2015Q3 | -3.2 million USD | 2.1 million USD |
| 2015Q2 | -1.2 million USD | 1.2 million USD |
| 2015Q1 | -2.1 million USD | 1.3 million USD |
| 2014Q4 | -2.9 million USD | 1.4 million USD |
| 2014Q3 | -1.5 million USD | 1.4 million USD |
| 2014Q2 | -2.2 million USD | 1.3 million USD |
| 2014Q1 | -1.2 million USD | 1.3 million USD |
| 2013Q4 | -3.7 million USD | 1.4 million USD |
| 2013Q3 | -716264 USD | 1.3 million USD |
| 2013Q2 | -1.3 million USD | 1.2 million USD |
| 2013Q1 | -2.3 million USD | 1.4 million USD |
| 2012Q4 | -1.9 million USD | 1.5 million USD |
| 2012Q3 | -2.6 million USD | 1.8 million USD |
| 2012Q2 | -2.8 million USD | 2.2 million USD |
| 2012Q1 | -2.8 million USD | 2.1 million USD |
| 2011Q4 | -2.4 million USD | 2.4 million USD |
| 2011Q3 | -2.4 million USD | 2.6 million USD |
| 2011Q2 | -2.4 million USD | 2.6 million USD |
| 2011Q1 | -2.7 million USD | 2.9 million USD |
| 2010Q4 | -4.2 million USD | 3.1 million USD |
| 2010Q3 | -3.4 million USD | 3.4 million USD |
| 2010Q2 | -4.5 million USD | 3.9 million USD |
| 2010Q1 | -4.7 million USD | 3.7 million USD |
| 2009Q4 | 363231 USD | 6.2 million USD |
| 2009Q3 | -9.3 million USD | 6.3 million USD |
| 2009Q2 | -1.8 million USD | 6.8 million USD |
| 2009Q1 | -1.2 million USD | 6.8 million USD |
| 2008Q4 | -4.1 million USD | 6.2 million USD |
| 2008Q3 | -7.9 million USD | 7.3 million USD |
| 2008Q2 | -4.9 million USD | 8.5 million USD |
| 2008Q1 | -10.8 million USD | 9.1 million USD |
| 2007Q4 | -2.1 million USD | 10.1 million USD |
| 2007Q3 | -3.6 million USD | 11.3 million USD |
| 2007Q2 | -1.3 million USD | 11.5 million USD |
| 2007Q1 | -1.4 million USD | 11.8 million USD |
| 2006Q4 | 176138 USD | 14.2 million USD |
| 2006Q3 | 2.4 million USD | 15.3 million USD |
| 2006Q2 | 1.5 million USD | 14.0 million USD |
| 2006Q1 | 147338 USD | 11.8 million USD |
| 2005Q4 | 805451 USD | 10.3 million USD |
| 2005Q3 | 769265 USD | 9.1 million USD |
| 2005Q2 | -40144 USD | 8.1 million USD |
| 2005Q1 | -596314 USD | 6.8 million USD |
| 2004Q4 | -835173 USD | 5.8 million USD |
| 2004Q3 | -1.4 million USD | 4.8 million USD |
| 2004Q2 | -1.3 million USD | 4.3 million USD |
| 2004Q1 | -779994 USD | 3.0 million USD |
| 2003Q4 | -952088 USD | 2.9 million USD |
| 2003Q3 | -781258 USD | 2.6 million USD |
| 2003Q2 | -893001 USD | 2.1 million USD |
| 2003Q1 | -1.0 million USD | 1.6 million USD |
| 2002Q4 | ? USD | 4.2 million USD |
NURO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -6.5 million USD | 5.9 million USD |
| 2022 | -4.4 million USD | 8.3 million USD |
| 2021 | -2.2 million USD | 8.3 million USD |
| 2020 | -2.0 million USD | 7.4 million USD |
| 2019 | -3.6 million USD | 9.3 million USD |
| 2018 | 23605 USD | 16.1 million USD |
| 2017 | -12.9 million USD | 17.1 million USD |
| 2016 | -14.9 million USD | 12.0 million USD |
| 2015 | -9.2 million USD | 7.3 million USD |
| 2014 | -7.8 million USD | 5.5 million USD |
| 2013 | -8.0 million USD | 5.3 million USD |
| 2012 | -10.0 million USD | 7.6 million USD |
| 2011 | -10.0 million USD | 10.4 million USD |
| 2010 | -16.9 million USD | 13.9 million USD |
| 2009 | -11.9 million USD | 26.1 million USD |
| 2008 | -27.7 million USD | 31.1 million USD |
| 2007 | -8.4 million USD | 44.6 million USD |
| 2006 | 4.3 million USD | 55.2 million USD |
| 2005 | 938258 USD | 34.3 million USD |
| 2004 | -4.3 million USD | 17.9 million USD |
| 2003 | -3.7 million USD | 9.2 million USD |
| 2002 | -4.8 million USD | 4.2 million USD |
| 2001 | -8.7 million USD | 3.5 million USD |
NURO
Price: $4.60
52 week price:
Earnings Per Share: -6.27 USD
P/E Ratio: -0.59
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Volume: 39500
Ebitda: -2.8 millionMarket Capitalization: 7.8 million